What We're Reading: Page 91
Industry reads hand-picked by our editors
Apr 18, 2023
-
Fierce Pharma
Struggling Gamida wins long-awaited FDA approval for Omisirge
-
FirstWord Pharma
Lilly pours another $1.6 billion to buoy drug manufacturing in home base
-
Bloomberg
Danaher Is Said to Shelve Takeover Pursuit of Catalent
-
Regulatory Focus
ORA head says attrition is outpacing hiring, decries flat funding for inspections
Apr 17, 2023
-
The Wall Street Journal
Demand for Obesity Drugs Has Insurers Paying Close Attention
-
Reuters
GSK’s antibiotic drug to treat uncomplicated UTIs meets main goals
-
Financial Times
Gates Foundation makes unusual investment in experimental cancer trial
-
The New York Times
CoolSculpting Promised to Zap Fat. For Some, It Brought Disfigurement.
Apr 14, 2023
-
LifeSciVC
Biotech Funding: Times Are Tough, Maybe For The Better
-
Science
Judicial interference with mifepristone
-
Bloomberg
Biden’s Medicare Chief Is Crafting How Program Will Negotiate Drug Prices
-
Chemical & Engineering News
Generative AI is dreaming up new proteins
Apr 13, 2023
-
STAT
A Parkinson’s ‘game changer,’ backed by Michael J. Fox, could lead to new diagnostics and, someday, treatments
-
KFF Health News
The Drug Company That Prospered Without Creating Any Drugs
-
Bloomberg
Zealand Pharma Taps Centerview to Explore Partnership Deals
-
The New York Times
Inside the Online Market for Overseas Abortion Pills
Apr 12, 2023
-
NBC News
Cancer drug shortages are creating dire circumstances for some patients
-
Boston Business Journal
More layoffs hit Biogen as drugmaker cuts multiple sclerosis team
-
CNN
Biden administration declares fentanyl laced with xylazine ‘an emerging threat’ in the US
-
Healthcare Dive
Last year was second-best year for healthcare PE deals, Bain finds
Apr 11, 2023
-
CNBC
Health misinformation is lowering U.S. life expectancy, FDA Commissioner Robert Califf says
-
The Washington Post
White House launching $5 billion program to speed coronavirus vaccines
-
The Financial Times
Eli Lilly warns EU will miss out on key drugs under planned change to patent rules
-
Kaiser Health News
For Uninsured People With Cancer, Securing Care Can Be Like Spinning a Roulette Wheel
Apr 10, 2023
-
The Wall Street Journal
The $76 Billion Diet Industry Asks: What to Do About Ozempic?
-
The Washington Post
Assisted-living homes are rejecting Medicaid and evicting seniors
-
Science
Judge dismisses claim that institute defamed David Sabatini in harassment case
Previous
